Fir Tree Capital Management
TLSI icon

Fir Tree Capital Management’s TriSalus Life Sciences TLSI Stock Holding History

Fir Tree Capital Management’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-167,450
Closed -$1.66M – 357
2022
Q3 		$1.66M Buy
167,450
+42,450
+34% +$420K 0.06% 360
2022
Q2 		$1.23M Hold
125,000
– – 0.04% 402
2022
Q1 		$1.22M Hold
125,000
– – 0.03% 409
2021
Q4 		$1.24M Hold
125,000
– – 0.03% 410
2021
Q3 		$1.24M Hold
125,000
– – 0.04% 312
2021
Q2 		$1.22M Hold
125,000
– – 0.05% 289
2021
Q1 		$1.21M Buy
+125,000
New +$1.27M 0.05% 272

Other funds holding TLSI

Magnetar Financial
Magnetar Financial Evanston, Illinois $10.2B AUM 0.67% 1-Year Est. Return
Dark Forest Capital Management
Dark Forest Capital Management San Juan, Puerto Rico $1.59B AUM 25.29% 1-Year Est. Return
SkyView Investment Advisors
SkyView Investment Advisors Shrewsbury, New Jersey $128M AUM 19.21% 1-Year Est. Return
Meteora Capital
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Boothbay Fund Management
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Virtu Financial
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Fir Tree Capital Management's TLSI Position: Q4 2022 in Review

Fir Tree Capital Management sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 167,450 shares — an estimated $1.66M sold.

Fir Tree Capital Management first reported a position in TLSI in Q1 2021 and held it in 7 quarters. The position peaked at $1.66M in Q3 2022. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

  • Fir Tree Capital Management reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
  • Fir Tree Capital Management sold 167,450 TriSalus Life Sciences shares in Q4 2022, an estimated $1.66M.
  • Fir Tree Capital Management first reported a position in TriSalus Life Sciences in Q1 2021 and held it in 7 quarters.
  • Fir Tree Capital Management's TriSalus Life Sciences position peaked at $1.66M in Q3 2022.
  • 9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on Fir Tree Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.